1. Home
  2. MDBH vs KYNB Comparison

MDBH vs KYNB Comparison

Compare MDBH & KYNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MDB Capital Holdings LLC common

MDBH

MDB Capital Holdings LLC common

HOLD

Current Price

$3.10

Market Cap

36.7M

Sector

N/A

ML Signal

HOLD

KYNB

Kyntra Bio Inc. Common Stock

N/A

Current Price

$8.19

Market Cap

31.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MDBH
KYNB
Founded
1997
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.7M
31.9M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
MDBH
KYNB
Price
$3.10
$8.19
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
6.2K
31.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$4.06
$0.15
Revenue Growth
N/A
N/A
52 Week Low
$3.00
$7.11
52 Week High
$7.20
$9.58

Technical Indicators

Market Signals
Indicator
MDBH
KYNB
Relative Strength Index (RSI) 42.82 49.31
Support Level N/A $7.37
Resistance Level $3.84 $8.88
Average True Range (ATR) 0.11 0.62
MACD 0.00 0.07
Stochastic Oscillator 33.90 57.18

Price Performance

Historical Comparison
MDBH
KYNB

About MDBH MDB Capital Holdings LLC common

MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.

About KYNB Kyntra Bio Inc. Common Stock

Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.

Share on Social Networks: